Howard A. 'Skip' Burris III, MD Joins Elephas Biosciences Board for Growth in Immunotherapy Innovation#USA#Immunotherapy#Madison#Elephas_Biosciences#Howard_Burris
Howard A. 'Skip' Burris III, MD Joins Elephas Biosciences Board for Growth in Immunotherapy Innovation
Elephas Biosciences has announced the addition of Howard A. 'Skip' Burris III, MD, to its Board of Directors, enhancing its leadership as it commercializes innovative cancer therapies.
third-news.com
July 9, 2026 at 3:11 PM
Howard A. 'Skip' Burris III, MD Joins Elephas Biosciences Board for Growth in Immunotherapy Innovation#USA#Immunotherapy#Madison#Elephas_Biosciences#Howard_Burris
Elephas Biosciences and Tes Pharma Collaborate on Lung Cancer Research Using Innovative Platform#United_States#Madison#Lung_Cancer#Elephas_Biosciences#Tes_Pharma
Elephas Biosciences and Tes Pharma Collaborate on Lung Cancer Research Using Innovative Platform
This article explores the groundbreaking collaboration between Elephas Biosciences and Tes Pharma, focusing on their efforts to enhance lung cancer therapy through innovative research technologies.
third-news.com
September 24, 2026 at 2:35 PM
Elephas Biosciences and Tes Pharma Collaborate on Lung Cancer Research Using Innovative Platform#United_States#Madison#Lung_Cancer#Elephas_Biosciences#Tes_Pharma
Elephas Biosciences Teams Up With Neuberg Diagnostics to Enhance Oncology Access in India#India#Ahmedabad#Oncology_Diagnostics#Elephas_Biosciences#Neuberg_Diagnostics
Elephas Biosciences Teams Up With Neuberg Diagnostics to Enhance Oncology Access in India
Elephas Biosciences announces an exclusive partnership with Neuberg Diagnostics, enhancing access to personalized oncology in India and expanding global strategy.
third-news.com
August 13, 2026 at 3:10 PM
Elephas Biosciences Teams Up With Neuberg Diagnostics to Enhance Oncology Access in India#India#Ahmedabad#Oncology_Diagnostics#Elephas_Biosciences#Neuberg_Diagnostics
Elephas Enhances elive™ Platform for Measuring Cytotoxicity in Targeted Therapies#USA#Madison#targeted_therapies#Elephas_Biosciences#elive_platform
Elephas Enhances elive™ Platform for Measuring Cytotoxicity in Targeted Therapies
Elephas Biosciences announces new data showcasing its elive™ platform's capability to evaluate cytotoxicity in targeted therapies, marking a significant advancement in cancer treatment.
third-news.com
July 24, 2026 at 1:03 PM
Elephas Enhances elive™ Platform for Measuring Cytotoxicity in Targeted Therapies#USA#Madison#targeted_therapies#Elephas_Biosciences#elive_platform
Elephas Forms Strategic Alliance with Invitrocue to Enhance Personalized Oncology Solutions in Southeast Asia#Singapore#oncology#Elephas_Biosciences#Invitrocue
Elephas Forms Strategic Alliance with Invitrocue to Enhance Personalized Oncology Solutions in Southeast Asia
Elephas and Invitrocue team up to expand the elive platform in Southeast Asia, blending innovative technologies in oncology for improved patient care.
third-news.com
July 21, 2026 at 3:03 PM
Elephas Forms Strategic Alliance with Invitrocue to Enhance Personalized Oncology Solutions in Southeast Asia#Singapore#oncology#Elephas_Biosciences#Invitrocue
Revolutionizing Cancer Research: Elephas Biosciences Partners with Mithrl for Advanced Tumor Profiling#USA#Immunotherapy#Madison#Elephas_Biosciences#Mithrl
Revolutionizing Cancer Research: Elephas Biosciences Partners with Mithrl for Advanced Tumor Profiling
Elephas Biosciences and Mithrl have joined forces, leveraging cutting-edge AI technology to enhance real-time tumor profiling, potentially transforming immunotherapy responses.
third-news.com
April 16, 2026 at 3:33 PM
Revolutionizing Cancer Research: Elephas Biosciences Partners with Mithrl for Advanced Tumor Profiling#USA#Immunotherapy#Madison#Elephas_Biosciences#Mithrl
Elephas Biosciences Partners with University of Louisville to Enhance Cancer Treatment Through Innovative Research#USA#Immunotherapy#Madison#University_of_Louisville#Elephas_Biosciences
Elephas Biosciences Partners with University of Louisville to Enhance Cancer Treatment Through Innovative Research
Elephas Biosciences collaborates with the University of Louisville to advance cancer treatment research, focusing on colorectal, liver, and pancreatic cancers.
third-news.com
February 24, 2026 at 4:49 PM
Elephas Biosciences Partners with University of Louisville to Enhance Cancer Treatment Through Innovative Research#USA#Immunotherapy#Madison#University_of_Louisville#Elephas_Biosciences
Elephas Biosciences Expands Leadership to Revolutionize Cancer Treatment with Live-Tumor Immunology#USA#Immunotherapy#Madison#Elephas_Biosciences#Live-Tumor_Technology
Elephas Biosciences Expands Leadership to Revolutionize Cancer Treatment with Live-Tumor Immunology
Elephas Biosciences announces the strengthening of its scientific and clinical team with new leadership appointments aimed at advancing its innovative immunology platform.
third-news.com
January 8, 2026 at 5:28 PM
Elephas Biosciences Expands Leadership to Revolutionize Cancer Treatment with Live-Tumor Immunology#USA#Immunotherapy#Madison#Elephas_Biosciences#Live-Tumor_Technology
Elephas Live™ Platform Revolutionizes Immunotherapy: Key Insights from Recent Journal Publication#USA#Immunotherapy#Madison#Cancer_Care#Elephas_Biosciences
Elephas Live™ Platform Revolutionizes Immunotherapy: Key Insights from Recent Journal Publication
A new paper in the Journal of Translational Medicine showcases Elephas Live™ Platform's ability to predict immunotherapy responses, enhancing cancer care.
third-news.com
January 6, 2026 at 4:27 PM
Elephas Live™ Platform Revolutionizes Immunotherapy: Key Insights from Recent Journal Publication#USA#Immunotherapy#Madison#Cancer_Care#Elephas_Biosciences
Elephas Biosciences Welcomes Dr. Josh Routh to Lead Their Laboratory's Innovations in Cancer Treatment#USA#Cancer_Treatment#Madison#Elephas_Biosciences#Dr._Josh_Routh
Elephas Biosciences Welcomes Dr. Josh Routh to Lead Their Laboratory's Innovations in Cancer Treatment
Elephas Biosciences appoints Dr. Josh Routh as Lab Director, enhancing their mission to utilize innovative platforms for predicting cancer treatment responses.
third-news.com
December 2, 2025 at 4:47 PM
Elephas Biosciences Welcomes Dr. Josh Routh to Lead Their Laboratory's Innovations in Cancer Treatment#USA#Cancer_Treatment#Madison#Elephas_Biosciences#Dr._Josh_Routh
Elephas Live Platform Sets New Milestone in Cancer Treatment at inDNA Life Sciences in India#India#Immunotherapy#Bhubaneswar#Elephas_Biosciences#inDNA_Life_Sciences
Elephas Live Platform Sets New Milestone in Cancer Treatment at inDNA Life Sciences in India
Elephas Biosciences introduces its innovative Live Platform, screening its first cancer patient at inDNA Life Sciences in India, enhancing immunotherapy access.
third-news.com
October 9, 2025 at 3:03 PM
Elephas Live Platform Sets New Milestone in Cancer Treatment at inDNA Life Sciences in India#India#Immunotherapy#Bhubaneswar#Elephas_Biosciences#inDNA_Life_Sciences
Elephas Biosciences Expands Advisory Board with Dr. Jerome Galon, Enhancing Its Immunotherapy Research#United_States#Immunotherapy#Madison,_Wisconsin#Dr._Jerome_Galon#Elephas_Biosciences
Elephas Biosciences Expands Advisory Board with Dr. Jerome Galon, Enhancing Its Immunotherapy Research
Elephas Biosciences has appointed Dr. Jerome Galon to its Scientific Advisory Board to support its innovative approach in predicting immunotherapy responses using live tissue.
third-news.com
September 25, 2025 at 3:34 PM
Elephas Biosciences Expands Advisory Board with Dr. Jerome Galon, Enhancing Its Immunotherapy Research#United_States#Immunotherapy#Madison,_Wisconsin#Dr._Jerome_Galon#Elephas_Biosciences